These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17520889)

  • 21. [Noncardiac chest pain and gastroesophageal reflux disease].
    Dimache M; Turcan E; Nătase M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
    Hall J; Dodd S; Durkin M; Sloan S
    Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population.
    Mohd H; Qua CS; Wong CH; Azman W; Goh KL
    J Gastroenterol Hepatol; 2009 Feb; 24(2):288-93. PubMed ID: 19054255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease].
    Maev IV; Kucheriavyĭ IuA; Danilin MS
    Eksp Klin Gastroenterol; 2003; (5):10-2, 192. PubMed ID: 14621603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trial: chest pain caused by presumed gastro-oesophageal reflux in coronary artery disease - controlled study of lansoprazole vs. placebo.
    Talwar V; Wurm P; Bankart MJ; Gershlick AH; de Caestecker JS
    Aliment Pharmacol Ther; 2010 Jul; 32(2):191-9. PubMed ID: 20456303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain.
    Mousavi S; Tosi J; Eskandarian R; Zahmatkesh M
    J Gastroenterol Hepatol; 2007 Feb; 22(2):218-21. PubMed ID: 17295874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease.
    Swiatkowski M; Budzyński J; Kłopocka M; Pulkowski G; Suppan K; Fabisiak J; Morawski W; Majer M
    Med Sci Monit; 2004 Sep; 10(9):CR524-9. PubMed ID: 15328486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type].
    Ivanova NG
    Eksp Klin Gastroenterol; 2002; (2):35-6, 101. PubMed ID: 12046384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of proton pump inhibitor as a diagnostic test in NCCP.
    Wong WM
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S14-7. PubMed ID: 16359342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The quality of life dynamics in patients with gastroesophageal reflux disease during rabeprazol therapy].
    Maev IV; Samsonov AA; Odintsova AN; Golubev NN; Iablunovskaia GI
    Eksp Klin Gastroenterol; 2009; (4):97-100. PubMed ID: 19967818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment.
    Bytzer P; Morocutti A; Kennerly P; Ravic M; Miller N;
    Scand J Gastroenterol; 2006 Oct; 41(10):1132-40. PubMed ID: 16990197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.
    Eggleston A; Katelaris PH; Nandurkar S; Thorpe P; Holtmann G;
    Aliment Pharmacol Ther; 2009 May; 29(9):967-78. PubMed ID: 19210493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole.
    Pace F; Coudsy B; DeLemos B; Sun Y; Xiang J; LoCoco J; Casalini S; Li H; Pelosini I; Scarpignato C
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):845-51. PubMed ID: 21900784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
    Hongo M; Miwa H; Kusano M;
    J Gastroenterol Hepatol; 2012 May; 27(5):913-8. PubMed ID: 22142515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is longer duration of proton pump inhibitor trial better for gastroesophageal reflux disease-related non-cardiac chest pain?
    Wu JC
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1477-8. PubMed ID: 19743991
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.
    Caos A; Breiter J; Perdomo C; Barth J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):193-202. PubMed ID: 16091056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wireless pH monitoring in patients with non-cardiac chest pain.
    Prakash C; Clouse RE
    Am J Gastroenterol; 2006 Mar; 101(3):446-52. PubMed ID: 16542279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The influence of gastroesophageal reflux on the course and therapy of bronchial asthma].
    Samoliński B
    Pol Merkur Lekarski; 2006 Oct; 21(124):307-9. PubMed ID: 17205765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.
    Miwa H; Sasaki M; Furuta T; Koike T; Habu Y; Ito M; Fujiwara Y; Wada T; Nagahara A; Hongo M; Chiba T; Kinoshita Y;
    Aliment Pharmacol Ther; 2007 Jul; 26(1):69-77. PubMed ID: 17555423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.